These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36497807)

  • 1. Experiences of Hope after Treatment of Hepatitis C Infection-A Qualitative Study.
    Sælør KT; Carlsen SL; Fadnes LT; Lorås L
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "I'm obviously not dying so it's not something I need to sort out today": Considering hepatitis C treatment in the era of direct acting antivirals.
    Wright C; Cogger S; Hsieh K; Goutzamanis S; Hellard M; Higgs P
    Infect Dis Health; 2019 May; 24(2):58-66. PubMed ID: 30541692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving access to care for people who inject drugs: Qualitative evaluation of project ITTREAT-An integrated community hepatitis C service.
    Phillips C; Schulkind J; O'Sullivan M; Edelman N; Smith HE; Verma S; Jones CJ
    J Viral Hepat; 2020 Feb; 27(2):176-187. PubMed ID: 31566851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
    Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
    Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring how hospitalization can alter hepatitis c virus treatment prioritization and trajectories in people who use drugs: A qualitative analysis.
    Levander XA; Vega TA; Seaman A; Korthuis PT; Englander H
    Subst Abus; 2022; 43(1):245-252. PubMed ID: 34161198
    [No Abstract]   [Full Text] [Related]  

  • 6. Views and experiences of hepatitis C testing and diagnosis among people who inject drugs: systematic review of qualitative research.
    Jones L; Atkinson A; Bates G; McCoy E; Porcellato L; Beynon C; McVeigh J; Bellis MA
    Int J Drug Policy; 2014 Mar; 25(2):204-11. PubMed ID: 24332457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Stigma is where the harm comes from": Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs.
    Goodyear T; Brown H; Browne AJ; Hoong P; Ti L; Knight R
    Int J Drug Policy; 2021 Oct; 96():103238. PubMed ID: 33902968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Sobriety equals getting rid of hepatitis C": A qualitative study exploring the interplay of substance use disorder and hepatitis C among hospitalized adults.
    Vega TA; Levander XA; Seaman A; Korthuis PT; Englander H
    J Subst Abuse Treat; 2021 Aug; 127():108337. PubMed ID: 34134860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Values and preferences for hepatitis C self-testing among people who inject drugs in Kyrgyzstan.
    Martínez-Pérez GZ; Nikitin DS; Bessonova A; Fajardo E; Bessonov S; Shilton S
    BMC Infect Dis; 2021 Jun; 21(1):609. PubMed ID: 34171990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Not just one box that you tick off' - Deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective.
    Marshall AD; Rance J; Grebely J; Treloar C
    Int J Drug Policy; 2022 Apr; 102():103610. PubMed ID: 35151085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HCV treatment access among Latinxs who inject drugs: qualitative findings from Boston, Massachusetts, 2016.
    Mittal A; Kosinski KC; Stopka TJ
    Harm Reduct J; 2019 Jul; 16(1):44. PubMed ID: 31288811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Directly observed hepatitis C treatment with opioid substitution therapy in community pharmacies: A qualitative study.
    Gunn J; Higgs P
    Res Social Adm Pharm; 2020 Sep; 16(9):1298-1301. PubMed ID: 31003763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Everybody living with a chronic disease is entitled to be cured": Challenges and opportunities in scaling up access to direct-acting antiviral hepatitis C virus treatment among people who inject drugs.
    Goodyear T; Ti L; Carrieri P; Small W; Knight R
    Int J Drug Policy; 2020 Jul; 81():102766. PubMed ID: 32416525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to hepatitis C treatment among secondary needle and syringe program clients and opportunities to intervene.
    Gunn J; McNally S; Ryan J; Layton C; Bryant M; Walker S; O'Mahony C; Pedrana A
    Int J Drug Policy; 2021 Oct; 96():103387. PubMed ID: 34330571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance between self-reported and current hepatitis C virus infection status in a sample of people who inject drugs in Sydney and Canberra, Australia.
    Gibbs D; Grebely J; Sutherland R; Larney S; Butler K; Dietze PM; Starr M; Peacock A
    Drug Alcohol Rev; 2021 Nov; 40(7):1349-1353. PubMed ID: 33759276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in Kenya: a retrospective cohort study.
    Akiyama MJ; Cleland CM; Lizcano JA; Cherutich P; Kurth AE
    Lancet Infect Dis; 2019 Nov; 19(11):1255-1263. PubMed ID: 31540840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "I want to feel young again": experiences and perspectives of young people who inject drugs living with hepatitis C in Vancouver, Canada.
    Jacob J; Goodyear T; Coulaud PJ; Hoong P; Ti L; Knight R
    Can J Public Health; 2021 Oct; 112(5):947-956. PubMed ID: 34115340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the Consensus hepatitis C Cascade of Care among people who inject drugs in Australia: Pre and post availability of direct acting antiviral therapy.
    Iversen J; Dore GJ; Starr M; Catlett B; Cunningham P; Geddes L; Maher L
    Int J Drug Policy; 2020 Sep; 83():102837. PubMed ID: 32645585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
    Fadnes LT; Aas CF; Vold JH; Ohldieck C; Leiva RA; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA;
    BMC Infect Dis; 2019 Nov; 19(1):943. PubMed ID: 31703669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engaging people who inject drugs in hepatitis C virus testing and prevention through community-based outreach, in Sydney, Australia.
    Coupland H; White B; Bates A; Park JN; Iversen J; Maher L
    Drug Alcohol Rev; 2019 Feb; 38(2):177-184. PubMed ID: 30652363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.